Conexeu Sciences, Inc. (CNXU)
7.07
+0.03
(+0.43%)
USD |
NASDAQ |
Aug 28, 16:00
7.14
+0.07
(+0.99%)
After-Hours: 20:00
Conexeu Sciences Enterprise Value : 181.88M for Aug. 28, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 181.88M |
| August 27, 2026 | 181.08M |
| August 26, 2026 | 179.34M |
| August 25, 2026 | 194.72M |
| August 24, 2026 | 201.68M |
| August 21, 2026 | 230.58M |
| August 20, 2026 | 245.03M |
| August 19, 2026 | 232.45M |
| August 18, 2026 | 260.01M |
| August 17, 2026 | 254.39M |
| August 14, 2026 | 230.85M |
| August 13, 2026 | 205.96M |
| August 12, 2026 | 188.30M |
| August 11, 2026 | 191.78M |
| August 10, 2026 | 187.23M |
| August 07, 2026 | 208.64M |
| August 06, 2026 | 219.34M |
| August 05, 2026 | 233.26M |
| August 04, 2026 | 235.66M |
| August 03, 2026 | 200.34M |
| July 31, 2026 | 215.06M |
| July 30, 2026 | 228.97M |
| July 29, 2026 | 203.82M |
| July 28, 2026 | 201.15M |
| July 27, 2026 | 198.20M |
| Date | Value |
|---|---|
| July 24, 2026 | 222.02M |
| July 23, 2026 | 237.54M |
| July 22, 2026 | 242.62M |
| July 21, 2026 | 250.92M |
| July 20, 2026 | 230.31M |
| July 17, 2026 | 255.73M |
| July 16, 2026 | 273.93M |
| July 15, 2026 | 291.86M |
| July 14, 2026 | 246.90M |
| July 13, 2026 | 269.38M |
| July 10, 2026 | 265.63M |
| July 09, 2026 | 257.87M |
| July 08, 2026 | 266.70M |
| July 07, 2026 | 246.63M |
| July 06, 2026 | 281.69M |
| July 02, 2026 | 283.29M |
| July 01, 2026 | 267.24M |
| June 30, 2026 | 284.90M |
| June 29, 2026 | 266.70M |
| June 26, 2026 | 285.97M |
| June 25, 2026 | 266.17M |
| June 24, 2026 | 278.74M |
| June 23, 2026 | 275.00M |
| June 22, 2026 | 318.61M |
| June 18, 2026 | 348.05M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| AbbVie, Inc. | 515.75B |
| Vericel Corp. | 2.028B |
| ACADIA Pharmaceuticals, Inc. | 4.128B |
| Alnylam Pharmaceuticals, Inc. | 31.39B |
| Anika Therapeutics, Inc. | 269.22M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.304M |
| Total Expenses (Quarterly) | 2.304M |
| EPS Diluted (Quarterly) | -0.0861 |
| Earnings Yield | -2.73% |